CA9 and adenocarcinoma: Our Genevestigator analysis [140] also showed an increased CA9 level in samples of intraductal papillary mucinous adenoma, adenocarcinoma, and invasive carcinoma from patients with pancreatic cancer compared to normal pancreatic duct tissue (Figure 5).